Germ Cell Tumor of the Vulva — Trials

Germ Cell Tumor of the Vulva — Trials · CancerIndex

Clinical trials

Registered studies

27 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 5
Recruiting: 2
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Children's Oncology Group
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02689219	Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors	terminated	Phase 2	18	Nabil AdraOTHER	1	Dec 10, 2019	clinicaltrials
NCT00042952	Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer	terminated	Phase 2	32	National Cancer Institute (NCI)NIH	1	Jan 17, 2013	clinicaltrials